BioCardia, Inc.
BCDANasdaqCIK 925741HealthcareFiscal year ends Dec 31
Reports and events: 369 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-1517:16 ET | DEF 14A | Proxy statementPeriod 2024-05-20 | 0001437749-24-012080 |
| 2024-04-0516:13 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-044271 |
| 2024-03-2716:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-24-009590 |
| 2024-03-2716:05 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001437749-24-009587 |
| 2024-03-1307:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-007538 |
| 2024-03-1216:33 ET | 8-K | 3.01 Delisting notice | 0001437749-24-007467 |
| 2024-03-1207:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-007371 |
| 2024-03-0408:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-006362 |
| 2024-02-2716:53 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-028261 |
| 2024-02-0909:58 ET | 8-K | 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-003561 |
| 2024-02-0807:03 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-003422 |
| 2024-02-0616:28 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-011115 |
| 2024-01-3107:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-24-002611 |
| 2024-01-0307:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-24-000289 |
| 2023-12-1907:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-034823 |
| 2023-12-1807:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-034653 |
| 2023-12-0606:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-033718 |
| 2023-12-0516:11 ET | 8-K/A | 5.07 Shareholder vote results | 0001437749-23-033648 |
| 2023-12-0516:05 ET | 8-K | 5.08 Item not in the standard list | 0001437749-23-033637 |
| 2023-11-2907:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-033141 |
| 2023-11-1617:15 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-032364 |
| 2023-11-1407:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-031752 |
| 2023-11-0816:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-030940 |
| 2023-11-0816:06 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001437749-23-030938 |
| 2023-10-1816:30 ET | 8-K | 5.07 Shareholder vote results | 0001437749-23-028517 |
| 2023-10-1106:04 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-028007 |
| 2023-09-1517:10 ET | 8-K | 3.01 Delisting notice | 0001437749-23-026045 |
| 2023-09-1216:15 ET | 8-K | 3.01 Delisting notice | 0001437749-23-025698 |
| 2023-09-0607:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-025255 |
| 2023-09-0507:15 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-025103 |
| 2023-09-0116:20 ET | DEF 14A | Proxy statementPeriod 2023-10-18 | 0001437749-23-025066 |
| 2023-08-2109:03 ET | 8-K | 5.08 Item not in the standard list | 0001437749-23-024228 |
| 2023-08-0916:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-022787 |
| 2023-08-0916:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001437749-23-022780 |
| 2023-07-2407:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-020488 |
| 2023-07-0507:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-019286 |
| 2023-06-3007:00 ET | 8-K | 1.02 Termination of a material agreement; 8.01 Other events | 0001437749-23-018959 |
| 2023-06-2117:23 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-018015 |
| 2023-06-2017:27 ET | 8-K | 8.01 Other events | 0001437749-23-017880 |
| 2023-06-2017:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-017872 |
| 2023-06-0807:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-016926 |
| 2023-05-2518:01 ET | SC 13D | Ownership report, active investor | 0001332596-23-000001 |
| 2023-05-2307:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-23-015525 |
| 2023-05-1016:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-23-013592 |
| 2023-05-1016:05 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001437749-23-013580 |
| 2023-05-0907:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-013142 |
| 2023-05-0117:04 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001437749-23-011950 |
| 2023-05-0116:34 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-23-011915 |
| 2023-04-2807:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-011492 |
| 2023-04-0407:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-23-009168 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 12:20 ET. Listed shows no prices and gives no investment advice.